For men | For women | |||||||
---|---|---|---|---|---|---|---|---|
Covariate | OR | 95% CI | p | OR | 95% CI | p | ||
Age (years) | .971 | .955 | .988 | 0.001*** | .958 | .934 | .984 | 0.001** |
MAT type | .984 | .579 | 1.67 | 0.951 | 1.42 | .726 | 2.76 | 0.308 |
MAT dose (mg/day) | 1.00 | .995 | 1.00 | 0.875 | .995 | .989 | 1.00 | 0.1142 |
Years on MAT | .965 | .917 | 1.02 | 0.171 | 1.07 | 1.02 | 1.12 | 0.006** |
Opioid-positive urine drug screens (% of total) | 1.01 | 1.01 | 1.02 | < 0.001*** | 1.01 | 1.00 | 1.02 | 0.007** |
Physical symptoms | 1.00 | .979 | 1.03 | 0.784 | .967 | .934 | 1.00 | 0.062 |
Psychological symptoms | 1.05 | 1.03 | 1.08 | < 0.001*** | 1.06 | 1.03 | 1.09 | < 0.001*** |